Raymond James & Associates’s Evolent Health EVH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
$498K Buy
17,598
+249
+1% +$7.04K ﹤0.01% 3103
2024
Q2
$332K Sell
17,349
-4,845
-22% -$92.6K ﹤0.01% 3292
2024
Q1
$728K Sell
22,194
-1,161
-5% -$38.1K ﹤0.01% 2794
2023
Q4
$771K Sell
23,355
-5,138
-18% -$170K ﹤0.01% 2672
2023
Q3
$776K Sell
28,493
-15,986
-36% -$435K ﹤0.01% 2603
2023
Q2
$1.35M Buy
44,479
+167
+0.4% +$5.06K ﹤0.01% 2298
2023
Q1
$1.44M Sell
44,312
-2,968
-6% -$96.3K ﹤0.01% 2221
2022
Q4
$1.33M Sell
47,280
-60,479
-56% -$1.7M ﹤0.01% 2265
2022
Q3
$3.87M Buy
107,759
+42,018
+64% +$1.51M ﹤0.01% 1552
2022
Q2
$2.02M Sell
65,741
-736
-1% -$22.6K ﹤0.01% 1971
2022
Q1
$2.15M Sell
66,477
-20,511
-24% -$662K ﹤0.01% 2079
2021
Q4
$2.41M Buy
86,988
+10,446
+14% +$289K ﹤0.01% 2041
2021
Q3
$2.37M Sell
76,542
-1,966
-3% -$61K ﹤0.01% 1980
2021
Q2
$1.66M Buy
78,508
+22,893
+41% +$483K ﹤0.01% 2229
2021
Q1
$1.12M Buy
55,615
+2,910
+6% +$58.8K ﹤0.01% 2426
2020
Q4
$845K Buy
52,705
+9,845
+23% +$158K ﹤0.01% 2440
2020
Q3
$532K Sell
42,860
-954
-2% -$11.8K ﹤0.01% 2564
2020
Q2
$312K Buy
43,814
+34
+0.1% +$242 ﹤0.01% 2878
2020
Q1
$238K Buy
43,780
+2,485
+6% +$13.5K ﹤0.01% 2906
2019
Q4
$374K Sell
41,295
-6,803
-14% -$61.6K ﹤0.01% 2928
2019
Q3
$346K Buy
48,098
+23,542
+96% +$169K ﹤0.01% 2904
2019
Q2
$195K Sell
24,556
-6,447
-21% -$51.2K ﹤0.01% 3248
2019
Q1
$390K Buy
31,003
+3,202
+12% +$40.3K ﹤0.01% 2819
2018
Q4
$555K Buy
27,801
+11,907
+75% +$238K ﹤0.01% 2480
2018
Q3
$451K Sell
15,894
-536
-3% -$15.2K ﹤0.01% 2770
2018
Q2
$346K Buy
16,430
+257
+2% +$5.41K ﹤0.01% 2916
2018
Q1
$230K Buy
16,173
+1,574
+11% +$22.4K ﹤0.01% 3043
2017
Q4
$180K Buy
14,599
+17
+0.1% +$210 ﹤0.01% 3068
2017
Q3
$260K Sell
14,582
-26
-0.2% -$464 ﹤0.01% 2857
2017
Q2
$370K Buy
+14,608
New +$370K ﹤0.01% 2579